川田 浩志

Kawada Hiroshi

  • 教授
  • 学位:博士(医学)

基本情報

所属

  • Undergraduate School of Medicine / Faculty of Medicine
  • Graduate School of Medicine / Course of Advanced Medical Science
  • Graduate School of Medicine / Course of Medical Science

詳細情報

研究キーワード

  • Hematology

研究分野

  • Life sciences Hematology and oncology

論文

Improvement in anemia and symptoms after switching from crovalimab to iptacopan in paroxysmal nocturnal hemoglobinuria

Redefining the Spectrum of Epstein-Barr Virus–Positive (EBV+) Diffuse Large B-cell Lymphoma and EBV+ Classic Hodgkin Lymphoma

Cord blood versus bone marrow/peripheral blood stem cell transplantation under reduced-intensity conditioning in high-risk acute myeloid leukemia and myelodysplastic syndromes

Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review

Philadelphia chromosome-positive de novo myelodysplastic syndrome with the p230 BCR::ABL1 fusion gene: a case report

Successful Treatment of Chronic Active Epstein-Barr Virus Infection Complicated by Cardiomyopathy in an Adult Patient.

Comparison of the Mutational Profile between BCL2- and BCL6-Rearrangement Positive Follicular Lymphoma.

TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy.

ALK-negative anaplastic large cell lymphoma with TP53 mutation developing during the administration of baricitinib for atopic dermatitis - A case report.

Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants.

Liposome-encapsulated progesterone efficiently suppresses B-lineage cell proliferation.

Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.

Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report.

[Disseminated toxoplasmosis after cord blood transplantation diagnosed at autopsy].

Impact of previous anthracycline therapy in patients with acute myeloid leukemia receiving venetoclax.

Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia.

Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome.

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B-Cell Lymphoma with MYC-Rearrangement, and Diffuse Large B-Cell Lymphoma with MYC-Cluster Amplification.

Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma.

The multilobated morphology is still a better prognosis factor of diffuse large B-cell lymphoma in the R-CHOP era.

所属学会

  • American Society of Hematology

共同研究・競争的資金等の研究課題

Development of a novel minimally invasive treatment for refractory and therapy-resistant hematological malignancies using food extracts.

Development of less invasive treatment for central nervous system invasion of refractory hematologic malignancies.

Development of a novel low-invasive treatment against acute leukemia adopting enhancement of oxidative stress

Subacute phase-cytokine therapy for the regeneraton of infarcted brain tissue

Myocardial Regeneration by Cytokine-mobilized Bone Marrow Stem Cells

Human hematopoietic reconstitution bu a single hematopoietic stem cell using intra-bone marrow transplantation

Cell therapy using bone marrow-derived stem cells, the possibility of its application in regenerative medicine.

In vitro expension of hematopoietic stem cells

Flow cytometric analysis in hematological malignancies

ResearchMapへ移動します

Contact Us

Inquiries about coverage

Public Affairs Division Public Affairs and Communications Department

Tel. 0463-63-4670(direct dialing)